Search

Author/Creator Grund, Birgit

1. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial. (12th March 2018)

Authors:
Arenas-Pinto, Alejandro; Grund, Birgit; Sharma, Shweta; Martinez, Esteban; Cummins, Nathan; Fox, Julie; Klingman, Karin L; Sedlacek, Dalibor; Collins, Simon; Flynn, Patricia M; Chasanov, William M; Kedem, Eynat; Katlama, Christine; Sierra-Madero, Juan; Afonso, Claudia; Brouwers, Pim; Cooper, David A
Journal:
Clinical infectious diseases
Issue:
Volume 67:Number 3(2018)
Page Start:
420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). (February 2022)

Authors:
Murray, Daniel D; Babiker, Abdel G; Baker, Jason V; Barkauskas, Christina E; Brown, Samuel M; Chang, Christina C; Davey, Victoria J; Gelijns, Annetine C; Ginde, Adit A; Grund, Birgit; Higgs, Elizabeth; Hudson, Fleur; Kan, Virginia L; Lane, H Clifford; Murray, Thomas A; Paredes, Roger; Parmar, Mah...
Journal:
Clinical trials
Issue:
Volume 19:Number 1(2022)
Page Start:
52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Issue 5 (May 2022)

Authors:
Self, Wesley H.; Sandkovsky, Uriel; Reilly, Cavan S.; Vock, David M.; Gottlieb, Robert L.; Mack, Michael; Golden, Kevin; Dishner, Emma; Vekstein, Andrew; Ko, Emily R.; Der, Tatyana; Franzone, John; Almasri, Eyad; Fayed, Mohamed; Filbin, Michael R.; Hibbert, Kathryn A.; Rice, Todd W.; Casey, Jonat...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 5(2022)
Page Start:
622
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Issue 10324 (5th February 2022)

Authors:
Polizzotto, Mark N.; Nordwall, Jacqueline; Babiker, Abdel G.; Phillips, Andrew; Vock, David M.; Eriobu, Nnakelu; Kwaghe, Vivian; Paredes, Roger; Mateu, Lourdes; Ramachandruni, Srikanth; Narang, Rajeev; Jain, Mamta K.; Lazarte, Susana M.; Baker, Jason V.; Frosch, Anne E.P.; Poulakou, Garyfallia; S...
Journal:
Lancet
Issue:
Volume 399:Issue 10324(2022)
Page Start:
530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. Issue 10 (October 2022)

Authors:
Ginde, Adit A.; Paredes, Roger; Murray, Thomas A.; Engen, Nicole; Grandits, Greg; Vekstein, Andrew; Ivey, Noel; Mourad, Ahmad; Sandkovsky, Uriel; Gottlieb, Robert L.; Berhe, Mezgebe; Jain, Mamta K.; Marines-Price, Rubria; Agbor Agbor, Barbine Tchamba; Mateu, Lourdes; España-Cueto, Sergio; Lladós,...
Journal:
Lancet
Issue:
Volume 10:Issue 10(2022)
Page Start:
972
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Health Utility Estimates and Their Application to HIV Prevention in the United States: Implications for Cost-Effectiveness Modeling and Future Research Needs. Issue 2 (July 2020)

Authors:
Whitham, Hilary K.; Hutchinson, Angela B.; Shrestha, Ram K.; Kuppermann, Miriam; Grund, Birgit; Shouse, R. Luke; Sansom, Stephanie L.
Journal:
MDM policy & practice
Issue:
Volume 5:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial. (26th June 2017)

Authors:
Hoy, Jennifer F; Grund, Birgit; Roediger, Mollie; Schwartz, Ann V; Shepherd, John; Avihingsanon, Anchalee; Badal‐Faesen, Sharlaa; de Wit, Stephane; Jacoby, Simone; La Rosa, Alberto; Pujari, Sanjay; Schechter, Mauro; White, David; Engen, Nicole Wyman; Ensrud, Kristine; Aagaard, Peer D; Carr, Andrew
Journal:
Journal of bone and mineral research
Issue:
Volume 32:Number 9(2017:Sep.)
Page Start:
1945
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. Issue 4 (April 2018)

Authors:
Molina, Jean-Michel; Grund, Birgit; Gordin, Fred; Williams, Ian; Schechter, Mauro; Losso, Marcello; Law, Matthew; Ekong, Ernest; Mwelase, Noluthando; Skoutelis, Athanasios; Wiselka, Martin J; Vandekerckhove, Linos; Benfield, Thomas; Munroe, David; Lundgren, Jens D; Neaton, James D
Journal:
Lancet
Issue:
Volume 5:Issue 4(2018)
Page Start:
e172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗